601 Pennsylvania Avenue, N.W.

Suite 900, South Building

Washington, D.C. 20004-2601

Tel: 202-220-3172

Fax: 202-639-8238


Board of Directors:

A. J. (Jim) Norby


Bill Kadereit

Vice President,

Legislative Affairs

John Leasher

Vice President,


JoAnn Alix-Gagain

Jane Banfield

Joseph R. (Dick) Ciocca

Robert Foresta

Chuck Gilbert



Michael Calabrese

Phyllis Borzi

Legislative Counsel:

Marta Bascom

Media Relations Director:

Ed Beltram

Member Organizations:

Aetna Retirees Association

Ameritech/SBC Retirees

AT&T Retirees (ACER)

Boeing Engineering Retirees Society

CWA-CUTW Retired Members

Daimler-Chrysler Retirees


Detroit Edison Alliance of Retirees (DEAR)

GM Retirees-Detroit Diesel

IBM Retirees

Johns Manville Retirees

Lucent Retirees Organization

Monsanto/Solutia Retirees

NAPRI (Prudential)

Northwestern Bell/Association of US WEST Retirees

Portland GE-Enron

Southern New England Tell

Retirees Association, Inc. (SRA)

TelCo Retirees Association

Attention Health Legislative Assistant - Please deliver ASAP

May 2, 2007

The Honorable Lisa Murkowski

United States Senate

709 Hart Senate Office Building
Washington, D.C. 20510-0202

Dear Senator Murkowski:

I want to thank you for your past actions showing your awareness of the burden that the high cost of prescription drugs is placing on many Americans. You understand that the reimportation of safe prescription drugs would do a great deal to lower prices. On behalf of the 2 million retirees and workers represented by the National Retiree Legislative Network, I urge your support for the Dorgan-Snowe Amendment to S. 1082. Their amendment would allow for the safe reimportation of prescription drugs.

Americans deserve to have the benefit of global competition in the pharmaceutical industry. The Dorgan-Snowe Amendment provides quality measures to insure that the FDA approves the drugs and the facilities where they are manufactured and packaged using counterfeit-resistant technologies.

Without this reimportation amendment, your constituents will continue to pay nearly two times as much for prescription drugs in the USA as do the citizens of many other countries. Americans—especially retirees living on fixed incomes—can no longer afford the high drug prices that are maintained through the monopoly power of pharmaceutical companies.

We believe that now is the time for the U.S. Senate to take action important to retirees and people with disabilities who are particularly hard hit by the high costs of prescription drugs.

Sincerely yours,

President, National Retiree Legislative Network